AI-generated editorial illustration for Sri Express.
Cabinet approved implementation of an updated pharmaceutical policy for the period to 2030, according to decisions published on 18 August.
The policy aimed to improve affordable access to essential medicines while strengthening quality, safety and supply-chain management. It responded to changes in health needs, international medicine markets and domestic manufacturing requirements.
The stated priorities included appropriate use of medical products, reducing waste and supporting local production with demonstrated quality and effectiveness.
The decision established a policy direction for the health sector. Its practical results would depend on subsequent implementation, procurement and regulatory work; the announcement itself did not confirm an immediate change in the price or availability of every medicine.
Source: news.lk
